---
name: ChemDiv
slug: chemdiv
site: cro
website_domain: chemdiv.com
summary: ChemDiv is a fully integrated target-to-clinic CRO offering discovery chemistry, medicinal chemistry, CADD, ADME/DMPK, toxicology, custom synthesis, and integrated drug discovery services across oncology, CNS, infectious disease, cardiometabolic, and immunology indications. Headquartered in San Diego, United States.
tagline: Integrated target-to-clinic CRO with AI-curated discovery chemistry and 1.6M+ compounds.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-09-21T07:02:24.029Z
services_count: 15
modalities_count: 4
indications_count: 6
locations_count: 4
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# ChemDiv

Integrated target-to-clinic CRO with AI-curated discovery chemistry and 1.6M+ compounds.

Listed on cro.directory.

## Summary

ChemDiv is a fully integrated target-to-clinic CRO offering discovery chemistry, medicinal chemistry, CADD, ADME/DMPK, toxicology, custom synthesis, and integrated drug discovery services across oncology, CNS, infectious disease, cardiometabolic, and immunology indications. Headquartered in San Diego, United States.

## At a glance

- HQ country: US

## Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- Safety Pharmacology
- GLP Toxicology
- Specialized & Large-Animal Models
- Translational Research

## Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Gene Therapy

## Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease

## Locations

- Headquarters, San Diego, CA, USA
- Representative - South Korea, Seongnam-si, Gyeongi-do, South Korea
- Representative - Japan, Tokyo, Tokyo, Japan
- Representative - China, Shanghai, Shanghai, China

## Long description

## Overview

ChemDiv is a fully integrated target-to-clinic contract research organization (CRO) headquartered in San Diego, CA. Over 32 years, the company has successfully completed hundreds of leads, drug candidates, and new drug programs for pharma, biotech, and academic partners globally.

## Core Capabilities

**Discovery & Chemistry Services:**
- Integrated drug discovery from target identification through lead optimization
- Medicinal chemistry and custom synthesis with FTE engagement
- In silico drug design (CADD) and computational chemistry
- Discovery biology and functional assays
- ADME and DMPK services
- Toxicology and safety assessment with GLP and CMP compliance
- Animal models and in vivo/in vitro pharmacology

**Compound Libraries & Screening:**
- 1.6 million stock-available compounds
- 12 million managed global inventory
- 2 trillion synthetically feasible chemistry structures
- 114 predesigned focused and targeted screening libraries
- 17 annotated active reference sets with >220,000 compounds and >25,000 targets
- Diversity libraries (2D and 3D)
- Preplated libraries covering 30B virtual space
- Building blocks, inhibitors, approved drugs, and natural product-based compounds

**Technology Platforms:**
- Hybrid AI/Machine Learning (ML) curated by scientists at each discovery step
- Proprietary platforms: molecular glues, stabilizers, degraders, covalent and non-covalent binders, bifunctional molecules, new-generation ADCs, RNA and DNA editing
- Adds ~50,000 novel diverse and targeted compounds annually

## Therapeutic Areas

Cancer, CNS/neurological, infectious disease, cardiometabolic, immunology, inflammation, and virology.

## Track Record

- 47 approved drugs developed with ChemDiv support
- 2,700+ satisfied customers
- 5 R&D hubs worldwide
- 30+ years of industrial experience
- Delivery of validated clinical assets in as little as 18 months

## Regulatory & Compliance

Services include CMC (Chemistry, Manufacturing, and Controls), GLP toxicology, and regulatory support.

## Related companies

- [Creative Bioarray](/companies/creative-bioarray) (High-Throughput Screening, In Vitro Pharmacology) — [Compare](/compare/chemdiv/creative-bioarray)
- [Reaction Biology](/companies/reactionbiology) (Discovery Research, Target Identification & Validation) — [Compare](/compare/chemdiv/reactionbiology)
- [ChemPartner](/companies/chempartner) (Discovery Research, Target Identification & Validation) — [Compare](/compare/chemdiv/chempartner)
- [BioDuro-Sundia](/companies/bioduro-sundia) (Discovery Research, Target Identification & Validation) — [Compare](/compare/bioduro-sundia/chemdiv)
- [Aragen Life Sciences](/companies/aragen) (Discovery Research, Target Identification & Validation) — [Compare](/compare/aragen/chemdiv)
- [Oncodesign Services](/companies/oncodesign-services) (Discovery Research, Target Identification & Validation) — [Compare](/compare/chemdiv/oncodesign-services)
- [Certara](/companies/certara) (Discovery Research, Target Identification & Validation) — [Compare](/compare/certara/chemdiv)
- [Southern Research](/companies/southernresearch) (Discovery Research, High-Throughput Screening) — [Compare](/compare/chemdiv/southernresearch)

_Profile last updated: 2026-09-21T07:02:24.029Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.